Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.

Eliza WiercinskaVera SchlipfenbacherGesine BugPeter BaderMareike VerbeekErhard SeifriedHalvard Bonig

Published in: Journal of translational medicine (2021)

General cryopreservation of allogeneic stem cell transplants is feasible. While more than half of the CD34+ cell content is lost, the remaining stem cells ensure timely engraftment.

Keyphrases

stem cells
stem cell transplantation
hematopoietic stem cell
cell therapy
bone marrow
coronavirus disease
sars cov
high dose
single cell
quality improvement